SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

PASCA, Antonio J; MONTERO, Julio C  y  PASCA, Laura A. Paradoja de la obesidad. Insuf. card. [online]. 2012, vol.7, n.2, pp. 67-70. ISSN 1852-3862.

    1. The World Health Report 2002, Reducing Risks, Promoting Healthy Life, World Health Organization, Geneva, Switzerland, 2002. [ Links ]

    2. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 2006; 113: 898-918. [ Links ]

    3. Hedley A, Ogden C, Johnson C et al. Prevalence of overweight and obesity among US children, adolescents, an adults, 1999 - 2002. JAMA 2004; 291: 2847-50. [ Links ]

    4. Pi-Sunyer X. A clinical view of the obesity problem. Science 2003; 299:859-860. [ Links ]

    5. Troiano R, Flegal K, Kuczmarski R et al. Overweight prevalence and trends for children and adolescents. The national health and nutrition examination surveys 1963 to 1991. Arch Pediatr Adolesc Med 1995; 149: 1085-1091. [ Links ]

    6. Morse SA, Bravo PE, Morse MC et al. The heart in obesity-hypertension. Expert Rev Cardiovasc Ther 2005;3:647-658. [ Links ]

    7. Klein S, Burke LE, Bray GA et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110: 2952-2967. [ Links ]

    8. Dwyer J, Stone E, Yang M et al. Predictors if overweight and over fatness in multiethnic pedriatric population. Child and adolescent trial cardiovascular health collaborative research group. Am J Clin Nutr 1998; 67: 602-610. [ Links ]

    9. Flegal KM, Graubard BI, Williamson, DF et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293(15):1861-1867. [ Links ]

    10. Aranceta J, Pérez Rodrigo C, Serra Majem L et al. Grupo colaborativo para el estudio de la obesidad en España. Prevalencia de obesidad en España: resultados del estudio SEEDO 2000. Med Clin (Barc) 2003; 120:608-612. [ Links ]

    11. Lavie CJ, Milani RV. Obesity and Cardiovascular Disease. Risk Factor, Paradox, and Impact of Weight Loss. J Am Coll Cardiol 2009; 53:1925-1932. [ Links ]

    12. Yoon KH, Lee JH, Son HY. Epidemic Obesity and Type 2 Diabetes in Asia. Lancet 2006; 368 (9548):1681-1688. [ Links ]

    13. Gu D, Reynolds K, Wu X et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365 (9468): 1398-1405. [ Links ]

    14. Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359:2105-20. [ Links ]

    15. Lewis CE, Jacobs DR, McCreath H et al. Weight gain continues in the 1990s: 10-year trends in weight and overweight in the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 2000;151: 1172-1181. [ Links ]

    16. Bolin K, Cawley JH. The economics of obesity. 1ra ed. Elsevier, 2007. [ Links ]

    17. Montero JC. Epidemiología de la obesidad en siete países de América Latina. Form contin nutr obes 2002;5: 325-330. [ Links ]

    18. Wang Y, Monteiro C, Popkin BM. Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China and Russia. Am J Clin Nutr 2002;75:971-977. [ Links ]

    19. Kain J, Vio F, Albala C. Obesity trends and determinant factors in Latin America. Cad Saúde Pública 2003; 19:S77-S86. [ Links ]

    20. Filozof C, González C, Sereday M et al. Obesity prevalence and trends in Latin-American countries. Obes Rev 2001; 2: 99 -106. [ Links ]

    21. McMillan D, Sattar N, Lean M y col.: ABC of obesity. Obesity and cancer. BMJ 2006 25; 333(7578):1109-11. [ Links ]

    22. Pasca A, Pasca L. Transición nutricional, demográfica y epidemiológica. Determinantes subyacentes de las enfermedades cardiovasculares. Insuf Card 2011; 6(1): 27-29. [ Links ]

    23. Temas de Salud. Obesidad y Sobrepeso. Centro de Prensa. Información general. Nota descriptiva N° 311. Marzo 2011. Disponible en http:// www.who.int/en/ [ Links ]

    24. Katz M, Pasca J, Vallejos J. Guía FAC III. Comité de Epidemiología y Prevención de FAC. Abordaje de la Obesidad. Oct 2005. www.fac.org.ar [ Links ]

    25. Anderson J, Konz E. Obesity and Disease Management: Effects of Weight Loss on Comorbid Conditions. Obes Res 2001; 9:S326-34. [ Links ]

    26. Dagenais GR, Yi Q, Mann JF et al. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005; 149:54-60. [ Links ]

    27. Prasad DS, Kabir Z, Dash AK et al. Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: a clinic epidemiological evidence summary. J Cardiovasc Dis Res 2011; 2(4):199-205. [ Links ]

    28. Bray GA. Medical Consequences of Obesity. J Clin Endocrinol Metab 2004, 89: 2583-9. [ Links ]

    29. Mokdad AH, Bowman BA, Ford ES et al. The continuing epidemics of obesity and diabetes in the United States. J Am Med Assoc 2001; 286:1195-200. [ Links ]

    30. Caterson ID, Hubbard V, Bray GA et al. American Heart Association. Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke. Group III: worldwide comorbidities of obesity. Circulation 2004; 110:e476-83. [ Links ]

    31. Yusuf S, Hawken S, Ounpuu S et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27.000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-9). [ Links ]

    32. Hubert HB, Feinleib M, McNamara PM et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968-77. [ Links ]

    33. Murphy N, MacIntyre K, Stewart S et al. Long-term cardiovascular consequences of obesity: 20 year follow-up of more than 15,000 middle-aged men and women (The Renfrew-Paisley Study). Eur Heart J 2006; 27: 96-106. [ Links ]

    34. Klenk J, Nagel G, Ulmer H et al. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol 2009; 24(2):83-910. [ Links ]

    35. Dyer A, Stamler J, Garside DB et al. Long-term consequences of body mass index for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. Ann Epidemiol 2004;14:101-108. [ Links ]

    36. Gruberg L, Weissman NJ, Waksman R et al. The impact of obesity on the short-term and long term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002 20;39(4):578-84. [ Links ]

    37. Dorner TE, Rieder A. Obesity paradox or reverse epidemiology: is high body weight a protective factor for various chronic conditions. Dtsch Med Wochenschr 2010; 135(9):413-8. [ Links ]

    38. Lavie CJ, Milani RV. Obesity and cardiovascular disease: the Hippocrates paradox? J Am Coll Cardiol 2003; 42:677-9. [ Links ]

    39. Kalantar-Zadeh K, Block G, Horwich T et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004; 43:1439-1444. [ Links ]

    40. Conard MW, Haddock CK, Poston WS et al. Impact of obesity on the health status of heart failure patients. J Card Fail. 2006;12: 700-706. [ Links ]

    41. Evangelista LS, Miller PS. Overweight and obesity in the context of heart failure: implications for practice and future research. J Cardiovasc Nurs 2006; 21:27-33. [ Links ]

    42. Lenz M, Richter T, Mhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009; 106(40):641-8. [ Links ]

    43. Dyer A, Stamler J, Garside DB et al. Long-term consequences of body mass index for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. Ann Epidemiol 2004;14:101-8. [ Links ]

    44. Romero-Corral A, Montori VM, Somers VK et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368(9536):666-78. [ Links ]

    45. Galal W, Van Domburg RT, Feringa HH et al. Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol 2007; 99(11):1485-1490. [ Links ]

    46. Uretsky S, Messerli FH, Bangalore S et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007; 120(10):863-870. [ Links ]

    47. Zamora E, Lupón J, Urrutia A et al. El índice de masa corporal influye en la mortalidad de los pacientes con insuficiencia cardiaca? Rev Esp Cardiol 2007; 60: 1127-34. [ Links ]

    48. Fonarow GC, Srikanthan P, Costanzo MR et al. An obesity paradox in acute heart failure: analysis of body mass index and in hospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007; 153(1):74-81. [ Links ]

    49. Oreopoulos A, Padwal R, Kalantar-Zadeh K et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156(1):13-22. [ Links ]

    50. Aursulesei V, Cozma A, Datcu MD. Obesity paradox. Rev Med Chir Soc Med Nat Iasi 2009; 113(4):1006-15. [ Links ]

    51. Lavie CJ, Milani RV, Ventura HO: Obesity and Cardiovascular Disease. Risk Factor, Paradox, and Impact of Weight Loss. J Am Coll Cardiol, 2009; 53:1925-32. [ Links ]

    52. Arena R, Lavie CJ. The obesity paradox and outcome in heart failure: is excess bodyweight truly protective? Future Cardiol 2010; 6(1):1-6. [ Links ]

    53. Curtis JP, Alexander JH, Huang Y et al. Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3). Am J Cardiol 2004; 94:279-83. [ Links ]

    54. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001;38:789-95. [ Links ]

    55. Cicoira M, Maggioni AP, Latini R et al. Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. Eur J Heart Fail 2007; 9:397-402. [ Links ]